Clinical Pharmacy CNS disorders

anxiety disorders

Topic overview

Start with the big picture

The lesson surveys generalized anxiety, panic, social anxiety, agoraphobia, specific phobia, separation anxiety, and selective mutism. It outlines SSRIs and SNRIs as first-line pharmacotherapy, with gradual dose titration and a delayed therapeutic response. Buspirone and other adjuncts are considered alongside benzodiazepines for short-term relief, including their distinct risks. CBT and exposure therapy, with supportive approaches such as relaxation, exercise, and sleep hygiene, are central non-pharmacologic options. Further topics include treatment duration and discontinuation, follow-up assessment with anxiety scales, adverse effects and interaction risks, and considerations for pregnancy, lactation, and older adults. The full lesson also addresses treatment-resistant anxiety and relevant mechanisms and pathways.

Learning objectives

What you'll learn

  • Identify the anxiety disorders included in the lesson.
  • Distinguish first-line pharmacotherapy from adjunctive and short-term options.
  • Describe the role of CBT, exposure therapy, and supportive lifestyle measures.
  • Recognize key monitoring, safety, and special-population considerations.
  • Summarize principles of treatment duration and discontinuation.
Ready for the complete lesson?

Continue your study

Work through the complete notes and reinforce the topic with the study tools available in the full lesson.

PharmaProLearn

Excel Beyond Limits